This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05202509
Recruitment Status : Recruiting
First Posted : January 21, 2022
Last Update Posted : March 5, 2024
Monash University
Information provided by (Responsible Party):
NewAmsterdam Pharma

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2026
Estimated Study Completion Date : November 2026